Effects of Ketoconazole and Rifampicin on the Pharmacokinetics of Gemigliptin, a Dipeptidyl Peptidase-IV Inhibitor: A Crossover Drug–Drug Interaction Study in Healthy Male Korean Volunteers
Keywords: کتوکونازول; CYP3A4; drug–drug interaction; gemigliptin; ketoconazole; LC15-0444; rifampicin